Severe thrombocytopenia after trastuzumab retreatment: a case report

BACKGROUND: Trastuzumab prolongs survival of human epidermal growth factor receptor 2-positive breast cancer patients in both the adjuvant and metastatic settings. Currently toxicity data are not available on retreatment of metastatic breast cancer patients who relapse after adjuvant trastuzumab. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Pino, Maria Simona, Angiolini, Catia, Fioretto, Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851485/
https://www.ncbi.nlm.nih.gov/pubmed/24093447
http://dx.doi.org/10.1186/1756-0500-6-400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851485/
https://www.ncbi.nlm.nih.gov/pubmed/24093447
http://dx.doi.org/10.1186/1756-0500-6-400

Ejemplares similares